Skip to main content

Day: March 11, 2026

E Ink Ranked Global Top 1% in the 2026 Sustainability Yearbook

CSA Score of 93 Sets New Industry RecordE Ink Tops S&P Global Sustainability Yearbook RankingsE Ink recognized as a Global Top 1% company in the S&P Global Sustainability Yearbook 2026BILLERICA, Mass., March 11, 2026 (GLOBE NEWSWIRE) — E Ink (8069.TW), the global leader in ePaper technology, announced that it has been recognized as a Global Top 1% company in the S&P Global Sustainability Yearbook 2026. In the Electronic Equipment, Instruments & Components industry category, E Ink achieved a Corporate Sustainability Assessment (CSA) score of 93, marking the second consecutive year it has earned—and surpassed—the highest score in the global industry. The S&P Global Sustainability Yearbook evaluates over 9,200 companies across 59 industries worldwide and selects top-performing companies based on CSA...

Continue reading

Broadcom Delivers Industry’s First 400G/lane Optical DSP for Next-Generation AI Networks

3nm 400G/lane technology enables best-in-class 1.6T transceivers and lays the foundation for 204.8T networks using 3.2T transceivers PALO ALTO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced the availability of its 3nm 400G/lane optical PAM-4 DSP, the Taurus™ BCM83640, optimized for 1.6T transceiver solutions with unprecedented bandwidth density and efficiency. The device features 400G/lane serial optical interfaces, which enable optical transceiver manufacturers to cost effectively deliver low power 1.6T pluggable modules to meet the growing bandwidth needs for AI data centers. Taurus™ BCM83640 Product HighlightsMonolithic 3nm 1.6T (8:4) PAM-4 DSP with integrated...

Continue reading

Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study

Access the Moleculin CEO Corner here HOUSTON, March 11, 2026 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next segment on its CEO Corner, a platform featuring Walter Klemp, Chief Executive Officer. The CEO Corner is designed to provide investors and stakeholders with enhanced insight into the Company’s corporate developments, clinical progress and strategic initiatives. As part of the segment, Mr. Klemp discussed progress on the Company’s pivotal MIRACLE Study evaluating Annamycin in combination with cytarabine (AnnAraC) for patients with relapsed or refractory Acute Myeloid Leukemia. Mr. Klemp explained that the adaptive Phase 3 trial was designed with input from the U.S. Food and Drug Administration and includes an initial cohort of 45 patients....

Continue reading

OpenVPP Launches 2.0 as Over $25M in Tokenized RWAs Power Next-Generation Energy Settlement on Base

San Francisco, CA, March 11, 2026 (GLOBE NEWSWIRE) —OpenVPP, a blockchain-based settlement layer for next-generation energy markets, today outlined the next phase of its platform as adoption grows across electric vehicles and distributed energy systems. Over the past year, more than 375 electric vehicles have been onboarded to the platform, representing real-world energy assets actively participating in settlement workflows. This growth reflects broader trends in global EV adoption, even as much of today’s electricity infrastructure continues to rely on legacy financial systems that reconcile transactions days or weeks after energy is delivered. As EV fleets scale worldwide, these delays create operational friction for operators, platforms, and consumers. OpenVPP was developed to address this gap by enabling near real-time financial...

Continue reading

Rapala VMC Corporation’s Financial Statement Release

RAPALA VMC CORPORATION, Financial Statement Release, March 11, 2026 at 3:00 p.m. EET Rapala VMC Corporation’s Financial Statement Release 2025:Continuous improvements through successful new prodcucts & improved operations January-December (FY) in brief:Net sales were 227.5 MEUR, up 3% from previous year (220.9). With comparable exchange rates sales were 6 % higher than last year. Comparable operating profit* was 8.4 MEUR (6.2).The improved profitability was primarily driven by increased sales and controlled operating expenses. Cash flow from operations was 5.5 MEUR (23.4). Net profit for the period was -4.9 EUR (0.4). Main negative impact related to non-cash foreign currency translation loss arising from dicontinued manufacturing operations. 2026 guidance: Full year comparable operating profit* to increase from the previous...

Continue reading

SKYX Announces it will Supply its Technologies to Enable a New Contemporary Apartment Community in New York as it Continues to Grow its Market Penetration

SKYX is Expected to Supply 10,000 of its Advanced Technologies to the New Pittsford Oaks Apartment Development in Pittsford, New York The Development will include 171 Apartments with Top-of-the-Line Amenities including an In-House Clubhouse, Fitness Center, Erie Canal Trail Access, and Underground Garage Heated Parking SKYX’s Technologies Expansion Provides Additional Opportunities for Future Recurring Revenues through Interchangeability, Upgrades, AI Services, Monitoring, Subscriptions, Among Others MIAMI, March 11, 2026 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive smart home platform technology company with over 100 pending and issued patents globally and 60 lighting and home décor websites, with a mission to make homes and buildings become safe...

Continue reading

Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone

“The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today reinforced how its strategic investment in PsyLabs strengthens its control over pharmaceutical-grade manufacturing and commercial supply chain infrastructure – a critical differentiator in the rapidly expanding psychedelic pharmaceutical sector. Through its investment in PsyLabs, Psyence BioMed has secured:A licensed, owned, and debt-free production operation. Source-level ibogaine supply. Natural psilocybin supply. GMP-compliant manufacturing capabilities. Intellectual property protection. Integrated analytical and chemistry laboratory infrastructure. A capital structure with no corporate...

Continue reading

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

DENVER, March 11, 2026 (GLOBE NEWSWIRE) — 247marketnews.com — In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture rounds, institutional syndicates, and aggressive capital deployment strategies. But what happens when a company advances a platform with billion-dollar potential without the backing of Silicon Valley mega-funding? That question is increasingly being asked about Kraig Biocraft Laboratories (OTCQB: KBLB). More than a decade ago, Kraig stood before members of the media at a press conference at the University of Notre Dame and announced that spider DNA had been successfully integrated into silkworms to produce composite fibers approaching the toughness of native spider silk. The milestone generated global interest....

Continue reading

Wrap Secures Canada Drone DFR-X Pre-Order and NLR Inventory Order

Canadian distributor strengthens access to Non-Lethal Response ecosystem for agencies across Canada MIAMI, March 11, 2026 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in Non-Lethal Response (“NLR”) solutions and public safety technology, today announced that Professional Security Products Corporation (“PSP Corp”), a distribution partner in Canada, has placed an inventory purchase order supporting the continued expansion of Wrap’s NLR ecosystem across the Canadian public safety market. The order includes BolaWrap® devices, WrapVision™ body-worn camera systems, and a pre-order for Wrap’s Drone First Responder Interdiction (“DFR-X”) drone platform, positioning PSP Corp. to support increasing demand for non-lethal solutions among Canadian law enforcement agencies and public...

Continue reading

Dr. Nikolas P. Tsakos, Founder & CEO of TEN Ltd., to be Interviewed Live Today on Bloomberg Surveillance

ATHENS, Greece, March 11, 2026 (GLOBE NEWSWIRE) — TEN Ltd. (NYSE: TEN) (“TEN” or the “Company”), a leading diversified crude, product and LNG tanker operator, announced today that the Founder and CEO, Dr. Nikolas P. Tsakos, will be interviewed on Bloomberg Surveillance by Tom Keene, Alexis Christoforous and Damian Sassower, live today at 9:40 a.m. EST. The live interview can be accessed through Bloomberg’s streaming platforms: Bloomberg Originals (Live Steam)https://www.bloomberg.com/originals YouTube:https://www.youtube.com/watch?v=f39oHo6vFLg Reflecting the Company’s strong financial results and near-full fleet utilization during the full year and fourth quarter of 2025, Dr. Tsakos will discuss the outlook for the tanker sector and the implications for global oil transportation and shipping routes amid heightened geopolitical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.